Avalo Therapuetics (AVTX) Misses Q1 EPS by 125c
Tweet
Share
E-mailGet Alerts AVTX Hot Sheet
Join SI Premium – FREE
Avalo Therapuetics (NASDAQ: AVTX) reported Q1 EPS of ($1.25).
For earnings history and earnings-related data on Avalo Therapuetics (AVTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- BiomX announces 1-for-10 reverse stock split effective Sept. 9
- Electra Therapeutics files for proposed IPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
